Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7550971

Concept 2023-01-01 to
2023-06-30
As at
2023-06-30
2023-04-01 to
2023-06-30
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-06-30
Key financial data of group
Business results of group
Net sales
500,570,000 JPY
1,386,748,000 JPY
839,543,000 JPY
Ordinary profit (loss)
-868,405,000 JPY
-1,278,820,000 JPY
-306,431,000 JPY
Profit (loss) attributable to owners of parent
-885,608,000 JPY
-1,349,539,000 JPY
-359,120,000 JPY
Comprehensive income
-861,390,000 JPY
-1,331,861,000 JPY
-236,098,000 JPY
Net assets
4,111,801,000 JPY
3,641,844,000 JPY
4,425,947,000 JPY
Total assets
4,565,118,000 JPY
4,266,453,000 JPY
5,218,214,000 JPY
Basic earnings (loss) per share
-53.81
-21.46
-99.10
-26.53
-25.25
Diluted earnings per share
Equity-to-asset ratio
0.899 xbrli:pure
0.850 xbrli:pure
0.847 xbrli:pure
Net cash provided by (used in) operating activities
-938,544,000 JPY
-708,390,000 JPY
585,341,000 JPY
Net cash provided by (used in) investing activities
-6,854,000 JPY
-125,696,000 JPY
-57,309,000 JPY
Net cash provided by (used in) financing activities
1,222,158,000 JPY
367,006,000 JPY
166,348,000 JPY
Cash and cash equivalents
3,684,625,000 JPY
3,379,048,000 JPY
4,684,699,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.